Skip to main content

Share story

AI Infrastructure

SageMaker adds ordered GPU fallback for training jobs

SageMaker adds ordered GPU fallback for training jobs Image: Primary
AWS says Amazon SageMaker AI Training and Processing Jobs can now use instance preference lists, allowing customers to submit up to five acceptable instance types in priority order. SageMaker checks the list and launches on the first available type; accelerated-compute jobs can also remain in an event-driven retry queue bounded by MaxPendingTimeInSeconds. Training jobs can place Flexible Training Plan capacity first and use on-demand instances as a fallback. AWS says customers must ensure their containers are compatible across the listed instance types.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from AWS Machine Learning Blog and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
AI Infrastructure
AI Infrastructure

Five technology giants commit more than $3T to future spending

Alphabet, Meta, Microsoft, Amazon and Oracle have committed more than $3T to future spending on data centres, leases, equipment and energy, The Next Web reported, citing Bloomberg. Alphabet accounts for more than $1T and Meta for more than $800B.

Products AI
Products AI

Salesforce's Rune acquisition agreement reportedly worth $375 million

Salesforce's agreement to acquire military logistics software developer Rune Technologies is worth $375 million in cash and stock, Resilience Media reported. Rune builds AI software that helps the US military predict supply needs and manage logistics in the field.

AI Science
AI Science

Insilico says AI-discovered Rentosertib has entered Phase III trials

Insilico Medicine says Rentosertib, its generative AI-discovered drug candidate also known as ISM001-055, has entered Phase III clinical trials for idiopathic pulmonary fibrosis. The company described the clinical advance in an announcement carried by News-Medical.Net.